N-substituted 8-(2,6-difluorobenzyl)oxy-2,6- dimethylimidazo1,2-apyrazin-3-carboxamide derivatives as stimulators of soluble guanylate cyclase (SGC) for the treatment of cardiovascular diseases

摘要

The present application relates to novel substituted imidazo[1,2-a]pyrazine carboxamides of general formula (I); to processes for their preparation, to their use, alone or in combinations, for the treatment and/or prophylaxis of diseases, and to their use for producing medicaments for the treatment and/or prophylaxis of diseases, in particular for the treatment and/or prophylaxis of cardiovascular disorders.